| Year |
Citation |
Score |
| 2020 |
Galoppin M, Berroir P, Soucy JP, Suzuki Y, Lavigne GJ, Gagnon JF, Montplaisir JY, Stip E, Blanchet PJ. Chronic Neuroleptic-Induced Parkinsonism Examined with Positron Emission Tomography. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32353194 DOI: 10.1002/Mds.28046 |
0.349 |
|
| 2019 |
Goubault E, Nguyen HP, Bogard S, Blanchet PJ, Bézard E, Vincent C, Sarna J, Monchi O, Duval C. Remnants of Cardinal Symptoms of Parkinson's Disease, Not Dyskinesia, Are Problematic for Dyskinetic Patients Performing Activities of Daily Living. Frontiers in Neurology. 10: 256. PMID 30967832 DOI: 10.3389/Fneur.2019.00256 |
0.311 |
|
| 2019 |
Lebel K, Goubault E, Bogard S, Duval C, Blanchet PJ. Parkinson's disease patients experiencing peak-dose dyskinesia redistribute involuntary movements throughout their body to improve motor control. Parkinsonism & Related Disorders. PMID 30935827 DOI: 10.1016/J.Parkreldis.2019.03.016 |
0.345 |
|
| 2019 |
Hernandez G, Mahmoudi S, Cyr M, Diaz J, Blanchet PJ, Lévesque D. Tardive dyskinesia is associated with altered putamen Akt/GSK-3β signaling in nonhuman primates. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30675935 DOI: 10.1002/Mds.27630 |
0.716 |
|
| 2018 |
Goubault E, Nguyen HP, Bogard S, Blanchet PJ, Bézard E, Vincent C, Langlois M, Duval C. Cardinal Motor Features of Parkinson's Disease Coexist with Peak-Dose Choreic-Type Drug-Induced Dyskinesia: Parkinson's Symptoms Coexist with Dyskinesia. Journal of Parkinson's Disease. PMID 29843253 DOI: 10.3233/Jpd-181312 |
0.31 |
|
| 2017 |
Lévesque C, Hernandez G, Mahmoudi S, Calon F, Gasparini F, Gomez-Mancilla B, Blanchet PJ, Lévesque D. Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugs. Neuroscience. PMID 28790021 DOI: 10.1016/J.Neuroscience.2017.07.068 |
0.734 |
|
| 2015 |
Mongeon D, Blanchet P, Bergeron S, Messier J. Impact of Parkinson's disease on proprioceptively based on-line movement control. Experimental Brain Research. PMID 26055990 DOI: 10.1007/S00221-015-4343-4 |
0.716 |
|
| 2014 |
Mahmoudi S, Lévesque D, Blanchet PJ. Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1125-33. PMID 24838395 DOI: 10.1002/Mds.25909 |
0.72 |
|
| 2013 |
Mahmoudi S, Blanchet PJ, Lévesque D. Haloperidol-induced striatal Nur77 expression in a non-human primate model of tardive dyskinesia. The European Journal of Neuroscience. 38: 2192-8. PMID 23551242 DOI: 10.1111/Ejn.12198 |
0.726 |
|
| 2013 |
Mongeon D, Blanchet P, Messier J. Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations. Brain and Cognition. 81: 271-82. PMID 23313834 DOI: 10.1016/J.Bandc.2012.12.001 |
0.704 |
|
| 2010 |
Tremblay PL, Bedard MA, Langlois D, Blanchet PJ, Lemay M, Parent M. Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease. Experimental Brain Research. 205: 375-85. PMID 20680249 DOI: 10.1007/S00221-010-2372-6 |
0.376 |
|
| 2009 |
Philibert M, Richer F, Blanchet PJ, Chouinard S, Dubarry AS, Fimbel E. Movement irregularities in atypical parkinsonian syndromes. Parkinsonism & Related Disorders. 15: 542-5. PMID 19103504 DOI: 10.1016/J.Parkreldis.2008.11.004 |
0.353 |
|
| 2009 |
Tremblay PL, Bedard MA, Levesque M, Chebli M, Parent M, Courtemanche R, Blanchet PJ. Motor sequence learning in primate: role of the D2 receptor in movement chunking during consolidation. Behavioural Brain Research. 198: 231-9. PMID 19041898 DOI: 10.1016/J.Bbr.2008.11.002 |
0.332 |
|
| 2009 |
Mongeon D, Blanchet P, Messier J. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing. Neuroscience. 158: 426-40. PMID 18996173 DOI: 10.1016/J.Neuroscience.2008.10.013 |
0.719 |
|
| 2004 |
Lemay S, Chouinard S, Blanchet P, Masson H, Soland V, Beuter A, Bédard MA. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 31-9. PMID 14687854 DOI: 10.1016/S0278-5846(03)00172-6 |
0.38 |
|
| 2003 |
Lemay S, Blanchet P, Chouinard S, Masson H, Soland V, Bédard MA. Poor tolerability of a transdermal nicotine treatment in Parkinson's disease. Clinical Neuropharmacology. 26: 227-9. PMID 14520160 DOI: 10.1097/00002826-200309000-00004 |
0.394 |
|
| 2003 |
Blanchet PJ. Antipsychotic drug-induced movement disorders. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 30: S101-7. PMID 12691483 |
0.33 |
|
| 1999 |
Blanchet PJ. Rationale for use of dopamine agonists in Parkinson's disease: review of ergot derivatives. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. S21-6. PMID 10451756 DOI: 10.1017/S0317167100000056 |
0.32 |
|
| 1998 |
Verhagen Metman L, Del Dotto P, Blanchet PJ, van den Munckhof P, Chase TN. Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Amino Acids. 14: 75-82. PMID 9871445 DOI: 10.1007/BF01345246 |
0.355 |
|
| 1998 |
Morissette M, Goulet M, Grondin R, Blanchet P, Bédard PJ, Di Paolo T, Lévesque D. Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies. The European Journal of Neuroscience. 10: 2565-73. PMID 9767387 DOI: 10.1046/J.1460-9568.1998.00264.X |
0.311 |
|
| 1998 |
Chase TN, Oh JD, Blanchet PJ. Neostriatal mechanisms in Parkinson's disease. Neurology. 51: S30-5. PMID 9711978 DOI: 10.1212/Wnl.51.2_Suppl_2.S30 |
0.337 |
|
| 1996 |
Blanchet PJ, Grondin R, Bédard PJ, Shiosaki K, Britton DR. Dopamine D1 receptor desensitization profile in MPTP-lesioned primates. European Journal of Pharmacology. 309: 13-20. PMID 8864687 DOI: 10.1016/0014-2999(96)00309-3 |
0.336 |
|
| 1996 |
Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys. Brain Research. 719: 129-37. PMID 8782872 DOI: 10.1016/0006-8993(96)00157-6 |
0.312 |
|
| 1996 |
Blanchet PJ, Grondin R, Bédard PJ. Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 91-4. PMID 8771074 DOI: 10.1002/mds.870110117 |
0.35 |
|
| 1996 |
Metman LV, Blanchet PJ, de Jong D, Mouradian MM, Chase TN. Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 257-60. PMID 8723141 DOI: 10.1002/mds.870110307 |
0.362 |
|
| 1996 |
Doucet JP, Nakabeppu Y, Bedard PJ, Hope BT, Nestler EJ, Jasmin BJ, Chen JS, Iadarola MJ, St-Jean M, Wigle N, Blanchet P, Grondin R, Robertson GS. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. The European Journal of Neuroscience. 8: 365-81. PMID 8714707 DOI: 10.1111/J.1460-9568.1996.Tb01220.X |
0.405 |
|
| 1996 |
Blanchet PJ, Gomez-Mancilla B, Di Paolo T, Bédard PJ. Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia? Fundamental & Clinical Pharmacology. 9: 434-42. PMID 8617407 DOI: 10.1111/J.1472-8206.1995.Tb00518.X |
0.484 |
|
| 1995 |
Kebabian JW, Blanchet PJ, Bedard P. The D-1 dopamine receptor: past, present and future an idiosyncratic review. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 19: 757-78. PMID 8539418 DOI: 10.1016/0278-5846(95)00129-J |
0.335 |
|
| 1995 |
Bédard PJ, Gomez-Mancilla B, Blanchet P, Grondin R, DiPaolo T. Dopamine-Receptor Families and the Treatment of Parkinsonʼs Disease Clinical Neuropharmacology. 18. DOI: 10.1097/00002826-199501001-00019 |
0.336 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1995 |
Calon F, Goulet M, Blanchet PJ, Martel JC, Piercey MF, Bédard PJ, Di Paolo T. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex. Brain Research. 680: 43-52. PMID 7663983 DOI: 10.1016/0006-8993(95)00229-J |
0.298 |
|
| 1997 |
Blanchet PJ, Papa SM, Metman LV, Mouradian MM, Chase TN. Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease. Neuroscience and Biobehavioral Reviews. 21: 447-53. PMID 9195602 DOI: 10.1016/S0149-7634(96)00038-3 |
0.297 |
|
| 2005 |
Beuter A, Barbo E, Rigal R, Blanchet PJ. Characterization of subclinical tremor in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 945-50. PMID 15806574 DOI: 10.1002/mds.20467 |
0.296 |
|
| 2012 |
Blanchet PJ, Normandeau L, Rompré PH. Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: A pilot study Schizophrenia Research. 137: 230-233. PMID 22309978 DOI: 10.1016/j.schres.2012.01.013 |
0.295 |
|
| 2003 |
van den Munckhof P, Luk KC, Ste-Marie L, Montgomery J, Blanchet PJ, Sadikot AF, Drouin J. Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development (Cambridge, England). 130: 2535-42. PMID 12702666 DOI: 10.1242/Dev.00464 |
0.291 |
|
| 2000 |
Calon F, Hadj Tahar A, Blanchet PJ, Morissette M, Grondin R, Goulet M, Doucet JP, Robertson GS, Nestler E, Di Paolo T, Bédard PJ. Dopamine-receptor stimulation: biobehavioral and biochemical consequences. Trends in Neurosciences. 23: S92-100. PMID 11052226 DOI: 10.1016/S1471-1931(00)00026-4 |
0.289 |
|
| 2012 |
Girard P, Monette C, Normandeau L, Pampoulova T, Rompré PH, De Grandmont P, Blanchet PJ. Contribution of orodental status to the intensity of orofacial tardive dyskinesia: An interdisciplinary and video-based assessment Journal of Psychiatric Research. 46: 684-687. PMID 22386652 DOI: 10.1016/j.jpsychires.2012.02.003 |
0.289 |
|
| 2000 |
Konitsiotis S, Blanchet PJ, Verhagen L, Lamers E, Chase TN. AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys. Neurology. 54: 1589-95. PMID 10762498 DOI: 10.1212/Wnl.54.8.1589 |
0.285 |
|
| 1998 |
Verhagen Metman L, Blanchet PJ, van den Munckhof P, Del Dotto P, Natté R, Chase TN. A trial of dextromethorphan in parkinsonian patients with motor response complications. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 414-7. PMID 9613730 DOI: 10.1002/Mds.870130307 |
0.283 |
|
| 1997 |
Morissette M, Goulet M, Soghomonian JJ, Blanchet PJ, Calon F, Bédard PJ, Di Paolo T. Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy. Brain Research. Molecular Brain Research. 49: 55-62. PMID 9387863 DOI: 10.1016/S0169-328X(97)00123-X |
0.283 |
|
| 1998 |
Blanchet PJ, Konitsiotis S, Hyland K, Arnold LA, Pettigrew KD, Chase TN. Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavenger. Experimental Neurology. 153: 214-22. PMID 9784281 DOI: 10.1006/Exnr.1998.6906 |
0.278 |
|
| 2004 |
Blanchet PJ, Calon F, Morissette M, Hadj Tahar A, Bélanger N, Samadi P, Grondin R, Grégoire L, Meltzer L, Di Paolo T, Bédard PJ. Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. Parkinsonism & Related Disorders. 10: 297-304. PMID 15196509 DOI: 10.1016/j.parkreldis.2004.02.011 |
0.276 |
|
| 2009 |
Potvin S, Blanchet P, Stip E. Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis. Schizophrenia Research. 113: 181-8. PMID 19608386 DOI: 10.1016/J.Schres.2009.06.010 |
0.276 |
|
| 2008 |
Beuter A, Hernández R, Rigal R, Modolo J, Blanchet PJ. Postural sway and effect of levodopa in early Parkinson's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 35: 65-8. PMID 18380279 |
0.272 |
|
| 1997 |
Goulet M, Morissette M, Calon F, Blanchet PJ, Falardeau P, Bédard PJ, Di Paolo T. Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis. Neuroscience. 79: 497-507. PMID 9200732 DOI: 10.1016/S0306-4522(96)00689-6 |
0.272 |
|
| 2004 |
Hadj Tahar A, Blanchet PJ, Doyon J. Motor-learning impairment by amantadine in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 187-94. PMID 14532914 DOI: 10.1038/Sj.Npp.1300317 |
0.265 |
|
| 2020 |
Lebel K, Duval C, Goubault E, Bogard S, Blanchet PJ. Can We Predict the Motor Performance of Patients With Parkinson's Disease Based on Their Symptomatology? Frontiers in Bioengineering and Biotechnology. 8: 189. PMID 32266228 DOI: 10.3389/fbioe.2020.00189 |
0.258 |
|
| 1977 |
Campenhout Jv, Blanchet P, Beauregard H, Papas S. Amenorrhea following the Use of Oral Contraceptives Fertility and Sterility. 28: 728-732. PMID 872953 DOI: 10.1016/S0015-0282(16)42673-7 |
0.256 |
|
| 1997 |
Blanchet PJ, Allard P, Grégoire L, Tardif F, Bédard PJ. Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 23: 189-93. PMID 8862840 DOI: 10.1017/S031716710003849X |
0.256 |
|
| 2002 |
Calon F, Morissette M, Ghribi O, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 26: 127-38. PMID 11853103 DOI: 10.1016/S0278-5846(01)00237-8 |
0.25 |
|
| 2016 |
Lavoie M, O'Connor K, leclerc J, Blanchet P, Morand-Beaulieu S. ERP and motor changes following therapy in the Gilles de la Tourette Syndrome International Journal of Psychophysiology. 108: 59-60. DOI: 10.1016/J.Ijpsycho.2016.07.197 |
0.249 |
|
| 2012 |
Blanchet PJ, Parent MT, Rompré PH, Lévesque D. Relevance of animal models to human tardive dyskinesia. Behavioral and Brain Functions : Bbf. 8: 12. PMID 22404856 DOI: 10.1186/1744-9081-8-12 |
0.246 |
|
| 2020 |
Goubault E, Bogard S, Blanchet PJ, Bézard E, Vincent C, Martino D, Sarna J, Monchi O, Duval C. Parkinsonian Symptoms, Not Dyskinesia, Negatively Affect Active Life Participation of Dyskinetic Patients with Parkinson's Disease. Tremor and Other Hyperkinetic Movements (New York, N.Y.). 10: 20. PMID 32775034 DOI: 10.5334/tohm.403 |
0.243 |
|
| 2005 |
Tahar AH, Blanchet PJ, Doyon J. Effect of amantadine on motor memory consolidation in humans Behavioural Pharmacology. 16: 107-112. PMID 15767846 DOI: 10.1097/00008877-200503000-00006 |
0.24 |
|
| 2015 |
O'Connor K, Lavoie M, Blanchet P, St-Pierre-Delorme MÈ. Evaluation of a cognitive psychophysiological model for management of tic disorders: an open trial. The British Journal of Psychiatry : the Journal of Mental Science. PMID 26250742 DOI: 10.1192/Bjp.Bp.114.154518 |
0.229 |
|
| 1977 |
Campenhout JV, Papas S, Blanchet P, Wyman H, Somma M. Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea. American Journal of Obstetrics and Gynecology. 127: 723-728. PMID 322489 DOI: 10.1016/0002-9378(77)90246-0 |
0.224 |
|
| 2016 |
Bonenfant D, Rompré PH, Rei N, Jodoin N, Soland VL, Rey V, Brefel-Courbon C, Ory-Magne F, Rascol O, Blanchet PJ. Characterization of Burning Mouth Syndrome in Patients with Parkinson's Disease. Journal of Oral & Facial Pain and Headache. 30: 318-322. PMID 27792799 |
0.222 |
|
| 1995 |
Papa SM, Blanchet PJ, Linfante I, Chase TN. Suppression of Levodopa-Induced Dyskinesias by an NMDA Receptor Antagonist in MPTP-Treated Monkeys: 3 Neurology. 45: 1417-1417. DOI: 10.1212/WNL.45.7.1417 |
0.219 |
|
| 1997 |
Metman LV, van den Munckhof P, Klaassen AA, Blanchet P, Mouradian MM, Chase TN. Effects of supra-threshold levodopa doses on dyskinesias in advanced Parkinson's disease. Neurology. 49: 711-3. PMID 9305328 |
0.21 |
|
| 2016 |
Morand-Beaulieu S, O'Connor K, Blanchet P, Leclerc J, Lavoie M. Normalisation of the P300 response following treatment in tic disorders and body-focused repetitive behaviors International Journal of Psychophysiology. 108: 141-142. DOI: 10.1016/J.Ijpsycho.2016.07.412 |
0.21 |
|
| 1998 |
Blanchet PJ, Konitsiotis S, Chase TN. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 798-802. PMID 9756148 DOI: 10.1002/mds.870130507 |
0.207 |
|
| 1999 |
Blanchet PJ, Fang J, Hyland K, Arnold LA, Mouradian MM, Chase TN. Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study. Neurology. 53: 91-5. PMID 10408542 |
0.205 |
|
| 2017 |
Sauvé G, Morand-Beaulieu S, O'Connor KP, Blanchet PJ, Lavoie ME. P300 Source Localization Contrasts in Body-Focused Repetitive Behaviors and Tic Disorders. Brain Sciences. 7. PMID 28671557 DOI: 10.3390/Brainsci7070076 |
0.204 |
|
| 2014 |
Blanchet PJ, Rompré PH. Clinimetric evaluation of the simpson-angus scale in older adults with schizophrenia Journal of Clinical Psychopharmacology. 34: 36-39. PMID 24145218 DOI: 10.1097/JCP.0b013e3182a6a2e3 |
0.204 |
|
| 2007 |
Kuznetsov Y, Khiat A, Blanchet PJ, Boulanger Y. Proton magnetic resonance spectroscopy study of dyskinesia patients. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 957-62. PMID 17377925 DOI: 10.1002/Mds.21459 |
0.203 |
|
| 1996 |
Blanchet PJ, Metman LV, Mouradian MM, Chase TN. Acute pharmacologic blockade of dyskinesias in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 580-1. PMID 8866502 DOI: 10.1002/mds.870110516 |
0.201 |
|
| 2009 |
Mongeon D, Blanchet P, Bergeron S, Messier J. P1.148 Effect of Parkinson's disease on adaptation-learning in a 3D virtual reality environment Parkinsonism & Related Disorders. 15: S67. DOI: 10.1016/S1353-8020(09)70270-6 |
0.194 |
|
| 1996 |
Soghomonian JJ, Pedneault S, Blanchet PJ, Goulet M, Di Paolo T, Bédard PJ. L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys. Brain Research. Molecular Brain Research. 39: 237-40. PMID 8804732 DOI: 10.1016/0169-328X(96)00078-2 |
0.191 |
|
| 2010 |
Lavigne G, Blanchet P, Khoury S, Carra MC, Rouleau G, Denis R. Headache and sleep: Guidance in recognition | Céphalées et sommeil : Un survol diagnostique et un guide pour le clinicien Douleur Et Analgesie. 23: 175-180. DOI: 10.1007/S11724-010-0207-7 |
0.189 |
|
| 1994 |
Blanchet PJ, Boucher R, Bédard PJ. Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeys. Brain Research. 650: 32-9. PMID 7953674 DOI: 10.1016/0006-8993(94)90203-8 |
0.178 |
|
| 2005 |
Blanchet PJ, Rompré PH, Lavigne GJ, Lamarche C. Oral dyskinesia: a clinical overview. The International Journal of Prosthodontics. 18: 10-9. PMID 15754887 |
0.176 |
|
| 2008 |
Khiat A, Kuznetsov Y, Blanchet PJ, Boulanger Y. Diffusion-weighted imaging and magnetization transfer imaging of tardive and edentulous orodyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1281-5. PMID 18512744 DOI: 10.1002/Mds.22081 |
0.176 |
|
| 2018 |
Morand-Beaulieu S, O'Connor KP, Blanchet PJ, Lavoie ME. Electrophysiological predictors of cognitive-behavioral therapy outcome in tic disorders. Journal of Psychiatric Research. 105: 113-122. PMID 30219560 DOI: 10.1016/J.Jpsychires.2018.08.020 |
0.174 |
|
| 2003 |
Blanchet PJ, Konitsiotis S, Mochizuki H, Pluta R, Emerich DF, Chase TN, Mouradian MM. Complications of a trophic xenotransplant approach in parkinsonian monkeys. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27: 607-12. PMID 12787846 DOI: 10.1016/S0278-5846(03)00048-4 |
0.174 |
|
| 1977 |
Blanchet P, Daloze P, Lesage R, Papas S, Campenhout JV. XY gonadal dysgenesis with gonadoblastoma discovered after kidney transplantation American Journal of Obstetrics and Gynecology. 129: 221-222. PMID 331956 DOI: 10.1016/0002-9378(77)90751-7 |
0.171 |
|
| 1998 |
Konitsiotis S, Kafetzopoulos E, Anastasopoulos D, Blanchet PJ. Opposite rotation induced by dopamine agonists in rats with unilateral lesions of the globus pallidus or substantia nigra. Behavioural Brain Research. 92: 77-83. PMID 9588687 DOI: 10.1016/S0166-4328(97)00127-7 |
0.165 |
|
| 2003 |
Blanchet PJ, Metman LV, Chase TN. Renaissance of amantadine in the treatment of Parkinson's disease. Advances in Neurology. 91: 251-7. PMID 12442683 |
0.163 |
|
| 2020 |
Blanchet PJ. A focused update on tardive dyskinesia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-31. PMID 32624027 DOI: 10.1017/cjn.2020.131 |
0.159 |
|
| 2015 |
Morand-Beaulieu S, O'Connor KP, Sauvé G, Blanchet PJ, Lavoie ME. Cognitive-behavioral therapy induces sensorimotor and specific electrocortical changes in chronic tic and Tourette's disorder. Neuropsychologia. 79: 310-21. PMID 26022060 DOI: 10.1016/J.Neuropsychologia.2015.05.024 |
0.158 |
|
| 2016 |
Morand-Beaulieu S, O'Connor KP, Richard M, Sauvé G, Leclerc JB, Blanchet PJ, Lavoie ME. The Impact of a Cognitive-Behavioral Therapy on Event-Related Potentials in Patients with Tic Disorders or Body-Focused Repetitive Behaviors. Frontiers in Psychiatry. 7: 81. PMID 27242551 DOI: 10.3389/Fpsyt.2016.00081 |
0.151 |
|
| 2001 |
Calon F, Lavertu N, Lemieux AM, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter. Synapse (New York, N.Y.). 40: 225-34. PMID 11304760 DOI: 10.1002/Syn.1045 |
0.15 |
|
| 2001 |
Lavigne GJ, Soucy JP, Lobbezoo F, Manzini C, Blanchet PJ, Montplaisir JY. Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism. Clinical Neuropharmacology. 24: 145-9. PMID 11391125 DOI: 10.1097/00002826-200105000-00005 |
0.147 |
|
| 2008 |
Blanchet PJ, Popovici R, Guitard F, Rompré PH, Lamarche C, Lavigne GJ. Pain and denture condition in edentulous orodyskinesia: comparisons with tardive dyskinesia and control subjects. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1837-42. PMID 18759358 DOI: 10.1002/mds.22102 |
0.136 |
|
| 2004 |
Blanchet PJ, Abdillahi O, Beauvais C, Rompré PH, Lavigne GJ. Prevalence of spontaneous oral dyskinesia in the elderly: a reappraisal. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 892-6. PMID 15300653 DOI: 10.1002/mds.20130 |
0.111 |
|
| 2018 |
Perrault M, Morand-Beaulieu S, O'Connor Kp, Blanchet Pj, Lavoie Me. Muscular tension regulation amongst patients with chronic tic disorders and body-focused repetitive behaviors during a Stimulus-Response Compatibility Inhibition Task: a surface electromyographic study International Journal of Psychophysiology. 131: S140. DOI: 10.1016/J.Ijpsycho.2018.07.376 |
0.111 |
|
| 2017 |
Blanchet PJ, Brefel-Courbon C. Chronic pain and pain processing in Parkinson's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 29031913 DOI: 10.1016/j.pnpbp.2017.10.010 |
0.095 |
|
| 2003 |
Blanchet PJ. The fluctuating Parkinsonian patient--clinical and pathophysiological aspects. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 30: S19-26. PMID 12691473 |
0.094 |
|
| 2013 |
Blanchet PJ, Sessle B, Lavigne G. Oral Pain and Movement Disorders in Aging Oral Healthcare and the Frail Elder: a Clinical Perspective. 31-50. DOI: 10.1002/9781118786789.ch3 |
0.091 |
|
| 2019 |
Morand-Beaulieu S, O'Connor KP, Blanchet PJ, Lavoie ME. F19. Motor Preparation in Obsessive-Compulsive Disorder: An LRP Study Biological Psychiatry. 85: S220. DOI: 10.1016/J.Biopsych.2019.03.556 |
0.087 |
|
| 2013 |
Rana AQ, Chaudry ZM, Blanchet PJ. New and emerging treatments for symptomatic tardive dyskinesia. Drug Design, Development and Therapy. 7: 1329-40. PMID 24235816 DOI: 10.2147/DDDT.S32328 |
0.069 |
|
| 2012 |
Deteix J, Djoumna G, Blanchet P, Fortin A, Cloutier A. MINIMIZING FLOORING STRIP WEIGHT: A SHAPE OPTIMIZATION APPROACH Bioresources. 7. DOI: 10.15376/Biores.7.2.1931-1947 |
0.069 |
|
| 2016 |
Cogulet A, Blanchet P, Landry V. Wood degradation under UV irradiation: A lignin characterization. Journal of Photochemistry and Photobiology. B, Biology. 158: 184-91. PMID 26974579 DOI: 10.1016/j.jphotobiol.2016.02.030 |
0.067 |
|
| 2011 |
Michaud N, Al-Akoum M, Gagnon G, Girard K, Blanchet P, Rousseau JA, Akoum A. Decreased concentrations of soluble interleukin-1 receptor accessory protein levels in the peritoneal fluid of women with endometriosis. Journal of Reproductive Immunology. 92: 68-73. PMID 21958553 DOI: 10.1016/J.Jri.2011.08.001 |
0.066 |
|
| 2020 |
Schorr D, Blanchet P. Improvement of White Spruce Wood Dimensional Stability by Organosilanes Sol-Gel Impregnation and Heat Treatment. Materials (Basel, Switzerland). 13. PMID 32098141 DOI: 10.3390/ma13040973 |
0.065 |
|
| 2020 |
Vu VA, Cloutier A, Bissonnette B, Blanchet P, Dagenais C. Steatite Powder Additives in Wood-Cement Drywall Particleboards. Materials (Basel, Switzerland). 13. PMID 33137904 DOI: 10.3390/ma13214813 |
0.064 |
|
| 2015 |
Cobut A, Beauregard R, Blanchet P. Reducing the environmental footprint of interior wood doors in non-residential buildings – part 2: ecodesign Journal of Cleaner Production. 109: 247-259. DOI: 10.1016/J.JCLEPRO.2015.05.068 |
0.06 |
|
| 2023 |
Dadras Chomachayi M, Blanchet P, Hussain A, Pepin S. Development of a novel sandwich-structured composite from biopolymers and cellulose microfibers for building envelope applications. Scientific Reports. 13: 21955. PMID 38082144 DOI: 10.1038/s41598-023-49273-0 |
0.057 |
|
| 2012 |
Barbuta C, Blanchet P, Cloutier A, Yadama V, Lowell E. OSB as substrate for engineered wood flooring European Journal of Wood and Wood Products. 70: 37-43. DOI: 10.1007/S00107-010-0494-Y |
0.056 |
|
| 2012 |
Fang C, Blanchet P, Cloutier A, Barbuta C. ENGINEERED WOOD FLOORING WITH A DENSIFIED SURFACE LAYER FOR HEAVY-DUTY USE Bioresources. 7. DOI: 10.15376/Biores.7.4.5843-5854 |
0.055 |
|
| 2012 |
Blanchet PJ, Girard P, Gauthier G, Pampoulova T, Rompré PH, De Grandmont P. Dental prosthetic rehabilitation approach in tardive dyskinesia with edentulism: A case report Schizophrenia Research. 136: 162-163. PMID 21798717 DOI: 10.1016/j.schres.2011.07.004 |
0.054 |
|
| 2000 |
Blanchet P, Cloutier A, Riedl B. Particleboard made from hammer milled black spruce bark residues Wood Science and Technology. 34: 11-19. DOI: 10.1007/S002260050003 |
0.054 |
|
| 2011 |
Barbuta C, Cloutier A, Blanchet P, Yadama V, Lowell E. Tailor made OSB for special application European Journal of Wood and Wood Products. 69: 511-519. DOI: 10.1007/S00107-010-0477-Z |
0.053 |
|
| 2019 |
Vu VA, Cloutier A, Bissonnette B, Blanchet P, Duchesne J. The Effect of Wood Ash as a Partial Cement Replacement Material for Making Wood-Cement Panels. Materials (Basel, Switzerland). 12. PMID 31466332 DOI: 10.3390/Ma12172766 |
0.053 |
|
| 2013 |
Belleville B, Stevanovic T, Cloutier A, Pizzi A, Salenikovich A, Blanchet P. Production and properties of wood-welded panels made from two Canadian hardwoods Wood Science and Technology. 47: 1005-1018. DOI: 10.1007/S00226-013-0554-7 |
0.053 |
|
| 2012 |
Barbuta C, Blanchet P, Cloutier A, Deteix J, Fortin A. Moisture-induced stresses in engineered wood flooring with OSB substrate Journal of Wood Science. 58: 327-335. DOI: 10.1007/S10086-012-1257-7 |
0.05 |
|
| 2017 |
Guy-Plourde S, De Blois M, Blanchet P, Barbuta C, Robichaud F. Wood Cladding in Non-residential Construction: Overcoming the Barriers to Leverage the Opportunities Bioresources. 13. DOI: 10.15376/biores.13.1.462-476 |
0.046 |
|
| 2012 |
Poaty B, Riedl B, Blanchet P, Blanchard V, Stafford L. Improved water repellency of black spruce wood surfaces after treatment in carbon tetrafluoride plasmas Wood Science and Technology. 47: 411-422. DOI: 10.1007/S00226-012-0505-8 |
0.043 |
|
| 2021 |
Hussain A, Blanchet P. Preparation of Breathable Cellulose Based Polymeric Membranes with Enhanced Water Resistance for the Building Industry. Materials (Basel, Switzerland). 14. PMID 34361503 DOI: 10.3390/ma14154310 |
0.043 |
|
| 2016 |
Essoua Essoua GG, Blanchet P, Landry V, Beauregard R. Pine Wood Treated with a Citric Acid and Glycerol Mixture: Biomaterial Performance Improved by a Bio-byproduct Bioresources. 11. DOI: 10.15376/BIORES.11.2.3049-3072 |
0.043 |
|
| 2016 |
Lafond C, Blanchet P, Landry V, Galimard P, Ménard S. The Effects of Acrylate Impregnation of Black Spruce Timber as Connectors Strength Bioresources. 11. DOI: 10.15376/BIORES.11.1.1753-1764 |
0.043 |
|
| 2019 |
Heidari MD, Lawrence M, Blanchet P, Amor B. Regionalised Life Cycle Assessment of Bio-Based Materials in Construction; the Case of Hemp Shiv Treated with Sol-Gel Coatings. Materials (Basel, Switzerland). 12. PMID 31540180 DOI: 10.3390/ma12182987 |
0.042 |
|
| 2018 |
Hoang DT, Schorr D, Landry V, Blanchet P, Vanslambrouck S, Dagenais C. Preparation and characterisation of flame retardant encapsulated with functionalised silica-based shell. Journal of Microencapsulation. 1-30. PMID 30189763 DOI: 10.1080/02652048.2018.1521477 |
0.042 |
|
| 2013 |
Kaboorani A, Riedl B, Blanchet P. Ultrasonication Technique: A Method for Dispersing Nanoclay in Wood Adhesives Journal of Nanomaterials. 2013: 1-9. DOI: 10.1155/2013/341897 |
0.039 |
|
| 2012 |
Fang CH, Mariotti N, Cloutier A, Koubaa A, Blanchet P. Densification of wood veneers by compression combined with heat and steam European Journal of Wood and Wood Products. 70: 155-163. DOI: 10.1007/S00107-011-0524-4 |
0.039 |
|
| 2015 |
Cobut A, Blanchet P, Beauregard R. The environmental footprint of interior wood doors in non-residential buildings – part 1: life cycle assessment Journal of Cleaner Production. 109: 232-246. DOI: 10.1016/J.JCLEPRO.2015.04.079 |
0.038 |
|
| 2018 |
Padilla-Rivera A, Amor B, Blanchet P. Evaluating the Link between Low Carbon Reductions Strategies and Its Performance in the Context of Climate Change: A Carbon Footprint of a Wood-Frame Residential Building in Quebec, Canada Sustainability. 10: 2715. DOI: 10.3390/SU10082715 |
0.037 |
|
| 1999 |
Kato T, Montplaisir JY, Blanchet PJ, Lund JP, Lavigne GJ. Idiopathic myoclonus in the oromandibular region during sleep: a possible source of confusion in sleep bruxism diagnosis. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 865-71. PMID 10495054 DOI: 10.1002/1531-8257(199909)14:5<865::AID-MDS1025>3.0.CO;2-0 |
0.034 |
|
| 2014 |
Riedl B, Angel C, Prégent J, Blanchet P, Stafford L. Effect of Wood Surface Modification by Atmospheric-Pressure Plasma on Waterborne Coating Adhesion Bioresources. 9. DOI: 10.15376/Biores.9.3.4908-4923 |
0.031 |
|
| 2020 |
Blanchet PJ, Lévesque D. Time for a New Slate in Tardive Dyskinesia Research. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32067258 DOI: 10.1002/mds.28003 |
0.031 |
|
| 2021 |
Cabral MR, Blanchet P. A State of the Art of the Overall Energy Efficiency of Wood Buildings-An Overview and Future Possibilities. Materials (Basel, Switzerland). 14. PMID 33917890 DOI: 10.3390/ma14081848 |
0.03 |
|
| 2015 |
Essoua Essoua GG, Blanchet P, Landry V, Beauregard R. Maleic Anhydride Treated Wood: Effects of Drying Time and Esterification Temperature on Properties Bioresources. 10. DOI: 10.15376/BIORES.10.4.6830-6860 |
0.03 |
|
| 2017 |
Cogulet A, Blanchet P, Landry V. The Multifactorial Aspect of Wood Weathering: A Review Based on a Holistic Approach of wood Degradation Protected by Clear Coating Bioresources. 13. DOI: 10.15376/BIORES.13.1.COGULET |
0.028 |
|
| 2018 |
Morand-Beaulieu S, O'Connor K, Blanchet P, Lavoie M. Electrophysiological evaluation of Tourette syndrome and prediction of treatment outcome International Journal of Psychophysiology. 131: S30. DOI: 10.1016/J.Ijpsycho.2018.07.094 |
0.028 |
|
| 2014 |
Kaboorani A, Blanchet P. Determining the Linear Viscoelastic Region of Sugar Maple Wood by Dynamic Mechanical Analysis Bioresources. 9. DOI: 10.15376/BIORES.9.3.4392-4409 |
0.025 |
|
| 2015 |
Landry V, Blanchet P, Boivin G, Bouffard J, Vlad M. UV-LED Curing Efficiency of Wood Coatings Coatings. 5: 1019-1033. DOI: 10.3390/COATINGS5041019 |
0.021 |
|
| 2018 |
Breton C, Blanchet P, Amor B, Beauregard R, Chang W. Assessing the Climate Change Impacts of Biogenic Carbon in Buildings: A Critical Review of Two Main Dynamic Approaches Sustainability. 10: 2020. DOI: 10.3390/SU10062020 |
0.02 |
|
| 2016 |
Gosselin A, Blanchet P, Lehoux N, Cimon Y. Main Motivations and Barriers for Using Wood in Multi-Story and Non-Residential Construction Projects Bioresources. 12. DOI: 10.15376/BIORES.12.1.546-570 |
0.02 |
|
| 2015 |
Blanchet P. Carleman Approximation on Riemannian Manifolds by Harmonic Functions with Newtonian Singularities American Journal of Applied Mathematics. 3: 1. DOI: 10.11648/J.AJAM.20150301.11 |
0.017 |
|
| 2016 |
Jafarian H, Demers CMH, Blanchet P, Laundry V. Impact of Indoor Use of Wood on the Quality of Interior Ambiances under Overcast and Clear Skies: Case Study of the Eugene H. Kruger Building, Québec City Bioresources. 11. DOI: 10.15376/BIORES.11.1.1647-1663 |
0.017 |
|
| 2009 |
Blanchet PJ, Lalonde B, Lavigne GJ. Orofacial pain and oromotor disorders | Douleur orofaciale et désordres oromoteurs Douleur Et Analgesie. 22: 103-111. DOI: 10.1007/s11724-009-0131-x |
0.017 |
|
| 2019 |
Appel-Cresswell S, Blanchet PJ, Wysocki J, Postuma RB. Gender and funding success. Lancet (London, England). 393: 2195-2196. PMID 31162073 DOI: 10.1016/S0140-6736(19)31107-9 |
0.01 |
|
| 2019 |
Mathis D, Blanchet P, Landry V, Lagière P. Thermal characterization of bio-based phase changing materials in decorative wood-based panels for thermal energy storage Green Energy & Environment. 4: 56-65. DOI: 10.1016/J.GEE.2018.05.004 |
0.01 |
|
| 2015 |
Blanchet PJ, Pourcher E. In memoriam: Paul J. Bédard, MD PhD: January 19, 1942-December 26, 2014. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 60: 132-3. PMID 26153581 |
0.01 |
|
| 2015 |
Di Paolo T, Blanchet PJ. In memoriam: Paul J. Bedard, MD PhD (1942-2014). Parkinsonism & Related Disorders. 21: 429. PMID 25737206 DOI: 10.1016/j.parkreldis.2015.01.014 |
0.01 |
|
| 2015 |
Blanchet PJ, Pourcher E. In memoriam: Paul J. Bédard, MD PhD: January 19, 1942-December 26, 2014. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 299-300. PMID 25702916 DOI: 10.1002/mds.26186 |
0.01 |
|
| 2015 |
Segovia F, Blanchet P, Barbuta C, Beauregard R. Aluminum-laminated Panels: Physical and Mechanical Properties Bioresources. 10. DOI: 10.15376/BIORES.10.3.4751-4767 |
0.01 |
|
| 2015 |
Cai X, Blanchet P. Electron-Beam Curing of Acrylate/Nanoparticle Impregnated Wood Products Bioresources. 10. DOI: 10.15376/BIORES.10.3.3852-3864 |
0.01 |
|
| 2013 |
Landry V, Blanchet P, Cormier LM. Water-Based and Solvent-Based Stains: Impact on the Grain Raising in Yellow Birch Bioresources. 8. DOI: 10.15376/BIORES.8.2.1997-2009 |
0.01 |
|
| Hide low-probability matches. |